Adapalene Patent Expiration
Adapalene is Used for treating acne vulgaris. It was first introduced by Galderma Laboratories Lp
Adapalene Patents
Given below is the list of patents protecting Adapalene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Differin | US7579377 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders | Feb 23, 2025 | Galderma Labs Lp |
| Differin | US7737181 | Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders | Aug 29, 2024 | Galderma Labs Lp |
| Differin | US7834060 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US7838558 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US7868044 | Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US7998467 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers | May 31, 2028 | Galderma Labs Lp |
| Differin | US8435502 | Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers | Sep 15, 2026 | Galderma Labs Lp |
| Differin | US8703820 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US8709392 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers | Sep 15, 2026 | Galderma Labs Lp |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Adapalene Generics
Several generic applications have been filed for Adapalene. The first generic version for Adapalene was by P And L Development Llc and was approved on Jun 2, 2010. And the latest generic version is by Taro Pharmaceuticals Inc and was approved on Jan 14, 2022.
Given below is the list of companies who have filed for Adapalene generic.
1. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB | Jun 30, 2010 |
2. TARO
Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Adapalene. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Jun 23, 2016 |
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jan 14, 2022 |
3. GLENMARK GENERICS
Glenmark Generics Inc Usa has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Glenmark Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jul 9, 2019 |
4. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Oct 27, 2014 |
5. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jul 1, 2010 |
6. ENCUBE ETHICALS
Encube Ethicals Pvt Ltd has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Encube Ethicals.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Jun 14, 2012 |
7. CALL INC
Call Inc Dba Rochester Pharmaceuticals has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Call Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | solution | Prescription | TOPICAL | AB | Sep 23, 2016 |
8. P AND L
P And L Development Llc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by P And L.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jun 2, 2010 |
9. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Jun 18, 2020 |